For the diabetes indication, Eli Lilly launched tirzepatide under brand name Mounjaro (27% market share), a once-weekly injection that activates receptors for two hormones in the body that are critical for appetite regulation and glycemic control, gastric inhibitory polypeptide (GIP), and glucagon-like peptide-1 (GLP-1)
It can also be used during physical performance
Note: prior to 2023, MASLD was known as non-alcoholic fatty liver disease (NAFLD)
Updated July 2026 The Ozempic and GLP-1 NAION lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, and Rybelsus failed to adequately warn patients and doctors about the potential risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), a serious eye injury that can cause sudden vision loss, optic nerve damage, partial blindness, or permanent blindness
Eon cy Cornita Syp 120ml 500mg Sugar Free Pack of 1 Rs